8-K: Borealis Foods Inc. Board Changes and Director Appointments

Sentiment:

Current Report


Borealis Foods Inc. announces board changes, including the resignation of Shiv Khemka and the appointment of two new directors, Zaure Algaziyeva and Pavel Mynzhanov, linked to a credit agreement.

Summary

  • Shiv Khemka has resigned from the Board of Directors and its committees (Audit, Compensation, Nominating and Corporate Governance) effective May 11, 2026.
  • The Board size has been increased from seven to eight directors.
  • Zaure Algaziyeva and Pavel Mynzhanov have been appointed as new directors until the next annual shareholder meeting.
  • These appointments are a result of the Credit Agreement with Oxus Capital PTE Ltd., dated April 27, 2026.
  • Zaure Algaziyeva is considered an independent director and has been appointed to the Audit, Compensation, and Nominating and Corporate Governance Committees.
  • Pavel Mynzhanov is a Director of Oxus Capital PTE Ltd., the company's lender and a significant shareholder, and is not considered independent.
  • Biographical details for Ms. Algaziyeva highlight extensive experience in FMCG production, logistics, and financial services.
  • Biographical details for Mr. Mynzhanov emphasize his experience in investment management and corporate finance with Oxus Capital PTE. Ltd. affiliates.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting on routine board changes and director appointments related to a previously disclosed credit agreement, without significant new financial information or strategic shifts.

Positives

  • Expansion of the Board of Directors to eight members, potentially bringing in new expertise.
  • Appointment of Zaure Algaziyeva, an independent director with significant experience in FMCG, logistics, and finance, to the Board and key committees.
  • Appointment of Pavel Mynzhanov, bringing investment management and corporate finance experience from a key lender and shareholder.
  • The new directors' appointments are tied to a credit agreement, suggesting a structured approach to financing and governance.

Negatives

  • Resignation of a director, Shiv Khemka, from the Board and its committees.
  • One of the new directors, Pavel Mynzhanov, is not considered independent due to his affiliation with the company's lender and significant shareholder, Oxus Capital PTE Ltd.

Risks

  • Potential for conflicts of interest given Pavel Mynzhanov's directorship at Oxus Capital PTE Ltd., the company's lender and a significant shareholder.
  • The company's reliance on financing from Oxus Capital PTE Ltd. could influence strategic decisions.
  • The departure of a director may indicate underlying issues, although the filing states no disagreement.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing regarding financial performance or strategic initiatives. The filing primarily concerns changes in board composition.

Management Comments

  • The Company believes that Ms. Algaziyevas extensive experience in FMCG production, logistics, banking, and international finance qualifies her to contribute effectively to strategic business development and corporate governance.
  • The Company believes that Mr. Mynzhanovs experience in investment management, corporate finance and strategic business operations qualifies him to serve on the Companys Board of Directors.

Industry Context

StockSavvy.ai notes that changes in board composition, especially those linked to financing agreements, are common in companies seeking growth or restructuring. The appointment of directors with specific industry and financial expertise, as seen with Ms. Algaziyeva and Mr. Mynzhanov, is a strategic move to enhance governance and operational oversight.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorShiv KhemkaZaure Algaziyeva2026-05-11Resignation of Shiv Khemka and appointment of new directors per Credit Agreement.
DirectorShiv KhemkaPavel Mynzhanov2026-05-11Resignation of Shiv Khemka and appointment of new directors per Credit Agreement.
Member of Audit CommitteeShiv KhemkaZaure Algaziyeva2026-05-11Resignation of Shiv Khemka and appointment of new directors per Credit Agreement.
Member of Compensation CommitteeShiv KhemkaZaure Algaziyeva2026-05-11Resignation of Shiv Khemka and appointment of new directors per Credit Agreement.
Member of Nominating and Corporate Governance CommitteeShiv KhemkaZaure Algaziyeva2026-05-11Resignation of Shiv Khemka and appointment of new directors per Credit Agreement.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board Size IncreaseThe size of the Board of Directors was increased from seven to eight directors.2026-05-11Potentially enhances board capacity and diversity of expertise.
Committee AppointmentsZaure Algaziyeva was appointed to the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.2026-05-11Strengthens committee oversight with new independent expertise.

Related Party Transactions

  • The appointments of Zaure Algaziyeva and Pavel Mynzhanov are pursuant to the terms of the Credit Agreement with Oxus Capital PTE Ltd.
  • Pavel Mynzhanov is a Director of Oxus Capital PTE Ltd., the company's lender and a significant shareholder, and previously served as Vice President of Fincraft Group LLP, an affiliate of Oxus Capital PTE. Ltd.
  • Oxus Capital PTE Ltd. is a party to the Credit Agreement and the Conversion Agreement with the Company.

Stakeholder Impact

  • Shareholders: May see enhanced board oversight with new directors, but also potential influence from the lender (Oxus Capital) through Mr. Mynzhanov.
  • Creditors: The company's relationship with its lender, Oxus Capital, is reinforced through board representation.
  • Management: Board composition changes may influence strategic direction and operational decisions.

Next Steps

  • The new directors will serve until the next annual meeting of shareholders or until their successors are elected or appointed.
  • Ms. Algaziyeva will participate in the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.
  • The company will continue to operate under the terms of the Credit Agreement with Oxus Capital PTE Ltd.

Key Dates

DateDescription
2026-04-27Date of Credit Agreement entered into between Borealis Foods Inc. and Oxus Capital PTE Ltd.
2026-05-01Date of previous Form 8-K filing disclosing the Credit Agreement.
2026-05-11Effective date of Shiv Khemka's resignation from the Board and its committees.
2026-05-11Effective date of the appointment of Zaure Algaziyeva and Pavel Mynzhanov to the Board.
2026-05-14Date of the filing of this Form 8-K report.

Keywords

Borealis Foods Inc., Form 8-K, Director Resignation, Director Appointment, Corporate Governance, Oxus Capital PTE Ltd., Credit Agreement, Board of Directors

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.